Early Access — free while we kick the tires
EdgarHawk

Burow Kristina

Director

Director 10% Owner
2 filings analyzed · 2 companies · Latest 2025-10-29

Companies

Company Buys Sells Direction
Neumora Therapeutics, Inc. NMRA 1 0 Net buying
Metsera, Inc. MTSR 4 0 Net buying

Activity

October 2025
high
Buy
1,915,700 shares
$4,999,977
Significance 7/10

Director Burow buys 1,915,700 shares of NMRA at $2.61 for $5.0M, boosting stake 46.4%; stock down 81.7% from $13.64 high but up 42.0% in 30 days.

Kristina Burow, a Director, purchased 1,915,700 shares at $2.61 on 2025-10-27 for a total of $5,000,000, increasing her holdings from 4,131,207 to 6,046,907 shares (a 46.4% increase in stake). This represents a substantial personal capital commitment at a deeply depressed valuation—the stock currently trades at $2.50, down 81.7% from its 52-week high of $13.64. Notably, 2 other insiders also bought within the past 14 days, establishing a cluster buy pattern. Her prior 5 buys at NMRA were all well-timed at the 90-day mark with returns ranging from +48.5% to +61.2%, and her cross-ticker track record shows an 88.89% 90-day win rate, though the company itself reported negative net income of $-52,731,000 for the most recent full fiscal year. The recent 30-day and 90-day price rallies (+42.0% and +27.6% respectively) follow this accumulation pattern, warranting close examination of what catalysts or operational developments may be signaling to insiders at this stage.

February 2025
2025-02-03 Metsera, Inc. MTSR
high
Buy
2,222,222 shares
$39,999,996
Significance 8/10

Director Burow purchases 2,222,222 shares ($40.0M at $18.00) within 2-day listing; part of 3-insider cluster buy

Kristina Burow, a director at Metsera Inc., purchased 2,222,222 shares in two separate transactions on 2025-02-03 for $39,999,996.00 at $18.00 per share—equivalent to a 36.5% increase in her shareholdings from 6.09M to 8.31M shares. This $40.0M commitment by a board member occurs in a newly listed stock (2 trading days post-IPO) and coincides with a cluster pattern of insider buying: 2 other insiders also acquired shares within the past 14 days. The current market price of $27.80 reflects early trading dynamics post-listing. This filing contains a derivative conversion flag; the shareholder's full derivative position resides in Form 4 Table II, which is not yet populated in our database, so the Table I holdings reported here represent only the cash-settled or converted portion of her total position.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access